We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+13.6%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.16B
AUM Growth
+$73.7M
(+6.8%)
Cap. Flow
+$24.1M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
27.51%
Holding
208
New
17
Increased
35
Reduced
30
Closed
120
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$29.5M |
| 2 |
Arcus Biosciences
RCUS
|
+$20.6M |
| 3 |
Revolution Medicines
RVMD
|
+$17.5M |
| 4 |
AFIB
Acutus Medical Inc
AFIB
|
+$16.2M |
| 5 |
American Well
AMWL
|
+$16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$27.4M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$25.1M |
| 3 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$20.5M |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$17.1M |
| 5 |
Health Catalyst
HCAT
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 90.35% |
| 2 | Industrials | 4.01% |
| 3 | Technology | 0.1% |
| 4 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
American Well
AMWL
$180M
| $17.9M | 1.54% |
+30,258
| New | +$16M |
|
27
Arvinas
ARVN
$518M
| $16.6M | 1.42% |
701,512
+234,512
| +50% | +$6.8M |
|
28
Idexx Laboratories
IDXX
$44.1B
| $16.2M | 1.39% |
41,199
+28,299
| +219% | +$10.5M |
|
|
AFIB
29
DELISTED
Acutus Medical Inc
AFIB
| $15.9M | 1.36% |
+532,158
| New | +$16.2M |
|
|
30
Arcus Biosciences
RCUS
$3.55B
| $15.8M | 1.36% |
+922,800
| New | +$20.6M |
|
31
Assembly Biosciences
ASMB
$498M
| $15.1M | 1.29% |
76,349
+21,589
| +39% | +$5.44M |
|
32
Repligen
RGEN
$7.96B
| $15M | 1.29% |
101,993
+19,610
| +24% | +$2.8M |
|
33
Boston Scientific
BSX
$69.5B
| $14.4M | 1.24% |
376,987
-197,608
| -34% | -$7.61M |
|
|
GBT
34
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $14.1M | 1.21% |
255,271
+26,000
| +11% | +$1.65M |
|
|
PRAH
35
DELISTED
PRA Health Sciences, Inc.
PRAH
| $13.5M | 1.16% |
132,620
+32,920
| +33% | +$3.36M |
|
|
FRLN
36
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $13.2M | 1.13% |
+56,190
| New | +$14.1M |
|
37
Cytosorbents Corp
CTSO
$22.7M
| $13M | 1.12% |
+1,629,989
| New | +$14.7M |
|
38
Sarepta Therapeutics
SRPT
$1.57B
| $13M | 1.11% |
92,274
+4,500
| +5% | +$684K |
|
39
Regeneron Pharmaceuticals
REGN
$78.5B
| $12.8M | 1.1% |
22,930
+4,892
| +27% | +$2.97M |
|
40
Novavax
NVAX
$1.2B
| $12.8M | 1.1% |
+118,200
| New | +$14.4M |
|
41
Incyte
INCY
$24.2B
| $12.5M | 1.07% |
138,774
-1,650
| -1% | -$159K |
|
42
ResMed
RMD
$30.6B
| $12.4M | 1.07% |
72,305
| – | – |
|
43
Bristol-Myers Squibb
BMY
$133B
| $11.9M | 1.02% |
197,574
-27,400
| -12% | -$1.65M |
|
44
Align Technology
ALGN
$12.1B
| $11.9M | 1.02% |
36,300
+24,300
| +203% | +$7.42M |
|
45
BioMarin Pharmaceuticals
BMRN
$11.6B
| $11.5M | 0.99% |
151,322
+19,699
| +15% | +$1.99M |
|
46
Johnson & Johnson
JNJ
$618B
| $11.1M | 0.95% |
+74,500
| New | +$11M |
|
|
SGEN
47
DELISTED
Seagen Inc. Common Stock
SGEN
| $10.7M | 0.92% |
54,716
-26,860
| -33% | -$4.5M |
|
48
Insulet
PODD
$11.5B
| $10.6M | 0.91% |
44,654
+11,916
| +36% | +$2.51M |
|
49
Molina Healthcare
MOH
$10.2B
| $10.5M | 0.9% |
57,262
-26,191
| -31% | -$4.77M |
|
|
HOLX
50
DELISTED
Hologic
HOLX
| $10.1M | 0.87% |
152,600
+113,100
| +286% | +$7.16M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q3 2020 Portfolio in Review
As of Q3 2020, Sectoral Asset Management held 208 positions worth $1.16B, up 6.8% from $1.09B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Sectoral Asset Management's Q3 2020 filing shows 17 new, 35 increased, 30 reduced and 120 closed positions. Its largest new stake was Arcus Biosciences: 922,800 shares worth $15.8M. The largest sale was HILL-ROM HOLDINGS, INC., an estimated $27.4M.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 86% a quarter earlier, followed by Industrials and Technology.
- Sectoral Asset Management's largest Q3 2020 buy was Arcus Biosciences: 922,800 shares worth $15.8M.
- Sectoral Asset Management added most to Labcorp in Q3 2020, an estimated $29.5M increase.
- Sectoral Asset Management's biggest Q3 2020 reduction was Change Healthcare Inc. Common Stock, cutting an estimated $17.1M.
- Sectoral Asset Management fully exited HILL-ROM HOLDINGS, INC. in Q3 2020, selling an estimated $27.4M.
- Sectoral Asset Management's ten largest holdings make up 28% of its $1.16B portfolio in Q3 2020.
- Sectoral Asset Management opened 17 new positions and closed 120 in Q3 2020.
- Sectoral Asset Management's portfolio value rose 6.8% quarter-over-quarter to $1.16B.
Based on Sectoral Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.